Neuronetics diskutieren
Neuronetics, Inc. (NASDAQ: STIM) had its price target lowered by analysts at Canaccord Genuity Group Inc. from $9.00 to $7.00. They now have a "buy" rating on the stock.
Ratings data for STIM provided by MarketBeat
Neuronetics, Inc. (NASDAQ: STIM) had its "overweight" rating re-affirmed by analysts at Piper Sandler. They now have a $8.00 price target on the stock, up previously from $7.00.
Ratings data for STIM provided by MarketBeat
Neueste Beiträge
Benchmark_Co_ in Codexis Inc. diskutieren